IDH1 and glioma: Compared to individuals with IDH-wild-type tumors, people with IDH-mutant gliomas have various treatment choices, like chemotherapy and radiation, and tend to respond better to particular medicines. The prognostic significance of IDH mutations in juvenile patients is less evident.